(Q33522014)

27 July 2017

title

VPAC receptor mediated tumor cell targeting by protamine based nanoparticles (English)

1 reference

27 July 2017

0 references

Raphaela Kaisler

3

0 references

Andreas Zimmer

object named as

Andreas Zimmer

8

0 references

Gottfried Köhler

6

object named as

Gottfried Köhler

1 reference

27 July 2017

Anna Ortner

1

1 reference

27 July 2017

Karin Wernig

2

1 reference

27 July 2017

Michael Edetsberger

4

1 reference

27 July 2017

Franz Hajos

5

1 reference

27 July 2017

Wilhelm Mosgoeller

7

1 reference

27 July 2017

publication date

1 July 2010

1 reference

Journal of Drug Targeting

27 July 2017

published in

1 reference

27 July 2017

volume

18

1 reference

27 July 2017

issue

6

1 reference

27 July 2017

page(s)

457-467

1 reference

A complete substitutional analysis of VIP for better tumor imaging properties.

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

VIP grafted sterically stabilized liposomes for targeted imaging of breast cancer: in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

New nonradioactive technique for vasoactive intestinal peptide-receptor-ligand-binding studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Enzymatic degradation of helodermin and vasoactive intestinal polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Receptor targeting for tumor localisation and therapy with radiopeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Antisense delivery using protamine-oligonucleotide particles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Peptide receptor radionuclide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

VPAC receptors for VIP and PACAP

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Peptidase modulation of airway effects of neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

The development of VIP-ellipticine conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Peptide receptors as molecular targets for cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Molecular dynamics in living cells observed by fluorescence correlation spectroscopy with one- and two-photon excitation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Vasoactive intestinal polypeptide type-1 receptor regulation. Desensitization, phosphorylation, and sequestration.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Protease inhibitors potentiate smooth muscle relaxation induced by vasoactive intestinal peptide in isolated human bronchi

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Mack Forster Award Lecture. Receptor nuclear medicine: vasointestinal peptide and somatostatin receptor scintigraphy for diagnosis and treatment of tumour patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

123I-vasoactive intestinal peptide (VIP) receptor scanning: Update of imaging results in patients with adenocarcinomas and endocrine tumors of the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Albumin–protamine–oligonucleotide nanoparticles as a new antisense delivery system. Part 1: Physicochemical characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10611860903508796

10.3109/10611860903508796

21 January 2018

Identifiers

DOI

1 reference

27 July 2017

1 reference